Anthracene based compounds as new L-type Ca2+ channel blockers: Design, synthesis, and full biological profile

Journal of Medicinal Chemistry

Volumn 52, Issue 5, 2009, Pages 1259-1262

  Bova, Sergio ^a   Saponara, Simona ^b   Rampa, Angela ^c   Gobbi, Silvia ^c   Cima, Lorenzo ^a   Fusi, Fabio ^b   Sgaragli, Giampietro ^b   Cavalli, Maurizio ^a   De Rios, Cristobal Los ^d   Striessnig, Jörg ^e   Bisi, Alessandra ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACENE; CALCIUM CHANNEL L TYPE; DEVAPAMIL; ISRADIPINE; MALEIMIDE; VERAPAMIL;

ARTICLE; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN;

ANIMALS; ANTHRACENES; ARTERIES; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DRUG DESIGN; MALEIMIDES; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; PROTEIN SUBUNITS; RABBITS; RADIOLIGAND ASSAY; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 64349086613     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801589x     Document Type: Article

References (23)

1. 2+ channels. Annu. Rev. Cell Dev. Biol. 2000, 16, 521-555.
2. Bova, S.; Travisi, L.; Debutto, P.; Cima, L.; Furnari, M.; Lucani, S.; Padrini, R.; Cargnelli, G. Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature. Br. J. Pharmacol. 1996, 117, 1041-1046.
3. Bova, S.; Cima, L.; Golovina, V.; Lucani, S.; Cargnelli, G. Norbormide: a calcium entry blocker agent endowed with selective vasoconstrictor activity for the rat small vessels. Cardiovasc. Drug Rev. 2001, 19, 226-233.
4. Bova, S.; Travisi, L.; Cima, L.; Lucani, S.; Golovina, V.; Cargnelli, G. Signaling mechanisms for the selective vasoconstrictor effect of norbormide on the rat small arteries. J. Pharmacol. Exp. Ther. 2001, 296, 458-463.
5. Cavalli, M.; Omiciuolo, L.; Cargnelli, G.; Cima, L.; Hopkins, B.; Bova, S. Distribution of the vasoconstrictor and vasorelaxant effects of norbormide along the vascular tree of the rat. Life Sci. 2004, 75, 2157-2165.
6. 2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes. Br. J. Pharmacol. 2002, 137, 323-328.
7. Bova, S.; Cavalli, M.; Cima, L.; Lucani, S.; Saponara, S.; Sgaragli, G.; Cargnelli, G.; Fusi, F. Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles. Eur. J. Pharmacol. 2003, 470, 185-191.
8. 2+-permeable cation channel. Circ. Res. 2001, 88, 325-332.
9. Sanders, K. M. Mechanisms of calcium handling in smooth muscles. J. Appl. Physiol. 2001, 91, 1438-1449.
10. Clapham, D. E.; Montell, C.; Schultz, G.; Julius, D. International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacol. Rev. 2003, 55, 591-596.
11. Karaki, H.; Ozaki, H.; Hori, M.; Mitsui-Saito, M.; Amano, K. I.; Harada, K. I.; Miyamoto, S.; Nakazawa, H.; Won, K. J.; Sato, K. Calcium movements, distribution, and function in smooth muscle. Pharmacol. Rev. 1997, 49, 157-230.
12. Gurney, A. M. Mechanisms of drug-induced vasodilation. J. Pharm. Pharmacol. 1994, 46, 242-251.
13. Kanaide, H.; Kobayashi, S.; Nishimura, J.; Hasegawa, M.; Shogakiuchi, Y.; Matsumoto, T.; Nakamura, M. Quin2 microfluorometry and effects of verapamil and diltiazem on calcium release from rat aorta smooth muscle cells in primary culture. Circ. Res. 1988, 63, 16-26.
14. 2+ channel interaction. Trends Pharmacol. Sci. 1990, 11, 38-44.
15. Kuriyama, H.; Kitamura, K.; Nabata, H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 1995, 47, 387-573.
16. 2+ channels in rat tail artery smooth muscle cells. Br. J. Pharmacol. 2002, 135, 1819-1827.
17. Lee, K. S.; Tsien, R. W. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 1983, 302, 790-794.
18. McDonald, T. F.; Pelzer, S.; Trautwein, W.; Pelzer, D. J. Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells. Physiol. Rev. 1994, 74, 365-507.
19. Penner, R. A Practical Guide to Patch Clamping. In Single-Channel Recording; Sakmann, B., Neher, E., Eds.; Plenum Press: New York, 1995, pp 3-30.
20. Glossmann, H.; Striessnig, J. Molecular properties of calcium channels. Rev. Physiol. Biochem. Pharmacol. 1990, 114, 1-105.
21. 2+ channels. Trends Pharmacol. Sci. 1998, 19, 108-115.
22. 2+ channels. J. Biol. Chem. 1998, 273, 27205-27212.
23. Cheng, Y.; Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.